Filing Details

Accession Number:
0000904454-14-000514
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-06-12 19:31:55
Reporting Period:
2014-06-10
Filing Date:
2014-06-12
Accepted Time:
2014-06-12 19:31:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1499807 K2M Group Holdings Inc. KTWO Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1212983 Wcas Management Corp C/O Welsh, Carson, Anderson &Amp; Stowe
320 Park Avenue, Suite 2500
New York NY 10022
No No Yes No
1212994 M Jonathan Rather C/O Welsh, Carson, Anderson &Amp; Stowe
320 Park Avenue, Suite 2500
New York NY 10022
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-06-10 660 $15.00 17,914 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The securities reported as directly beneficially owned by the designated Reporting Person may also be deemed to be indirectly beneficially owned by Jonathan M. Rather, who is the sole controlling stockholder of WCAS Management Corporation. Mr. Rather may also be deemed to indirectly beneficially own 21,879,386 shares of Common Stock held by Welsh, Carson, Anderson & Stowe XI, L.P. and 330,372 shares of Common Stock held by WCAS Capital Partners IV, L.P. Mr. Rather is a managing member of the respective sole general partners of such entities. Mr. Rather may also be deemed to indirectly beneficially own 73,734 shares of Common Stock held by WCAS XI Co-Investors LLC.
  2. Pursuant to Instruction 4(b)(iv) of Form 4, Mr. Rather has elected to report as indirectly beneficially owned the entire number of securities owned by such entities, however he disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him.
  3. Shares sold pursuant to the exercise of the underwriters' over-allotment option in connection with the Issuer's initial public offering.